Medtronic SynchroMed II Implantable Drug Infusion System. This system includes: Model 8870 Soft...

FDA Device Recall #Z-0788-2017 — Class I — October 3, 2016

Recall Summary

Recall Number Z-0788-2017
Classification Class I — Serious risk
Date Initiated October 3, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Neuromodulation
Location Minneapolis, MN
Product Type Devices
Quantity 22,298 software cards

Product Description

Medtronic SynchroMed II Implantable Drug Infusion System. This system includes: Model 8870 Software Application Card, Model 8840 N'Vision Clinician Programmer, and Model 8637 SynchroMed II Implantable Drug Infusion Pump (supplied in 20 ml or 40 ml reservoir size.) Product Usage: The SynchroMed II Programmable Pump is indicated when patient therapy requires the chronic infusion of the following drugs or fluids: Chronic intraspinal (epidural and intrathecal) infusion of preservative-free morphine sulfate sterile solution in the treatment of chronic intractable pain, Chronic intrathecal infusion of preservative-free ziconotide sterile solution for the management of severe chronic pain, Chronic intrathecal infusion of Lioresal Intrathecal (baclofen Injection ) in the management of serve spasticity, Chronic Intravascular Infusion of Floxuridine (FUDR) or methotrexate for the treatment of primary or metastatic cancer

Reason for Recall

Medtronic is following up to a May 2013 communication regarding the Priming Bolus function for the SynchroMed Infusion System. Medtronic is updating the Model 8870 software application card (to version AAU01) and the SynchroMed pump labeling to address the priming bolus issue.

Distribution Pattern

Worldwide Distribution - (US Nationwide) Internationally to Germany, Greece, Australia, United Kingdom, Switzerland, Italy, Norway, France, Canada, and Malta.

Lot / Code Information

software application cards with versions other than AAU01

Other Recalls from Medtronic Neuromodulation

Recall # Classification Product Date
Z-1043-2026 Class II A71200 Vanta" Clinician Programmer Application ... Dec 3, 2025
Z-0996-2026 Class II Restore Clinician Programmer Application (CP Ap... Nov 20, 2025
Z-1704-2025 Class II Enhanced Verify Evaluation Handset (CFN HH90130FA) Apr 3, 2025
Z-1543-2025 Class II Stimulation RC Clinician Programmer Application... Mar 4, 2025
Z-1506-2025 Class II A820 myPTM Software Application associated with... Jan 9, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.